Cleared Traditional

K151424 - The Progressive Orthopaedic Total Hip S...

K151424 is an FDA 510(k) clearance for The Progressive Orthopaedic Total Hip S..., manufactured by The Progressive Orthopaedic Company, LLC. The device is a Class 2 Orthopedic device with product code LPH cleared through the Traditional 510(k) pathway after a 426-day FDA review.

K151424 · The Progressive Orthopaedic Company, LLC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2016
Decision
426d
Days
Class 2
Risk

K151424 is an FDA 510(k) clearance for the The Progressive Orthopaedic Total Hip System. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by The Progressive Orthopaedic Company, LLC (North Palm Beach, US). The FDA issued a Cleared decision on July 27, 2016 after a review of 426 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all The Progressive Orthopaedic Company, LLC devices

FDA 510(k) Submission Details - K151424

510(k) Number K151424 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 2015
Decision Date July 27, 2016
Days to Decision 426 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
304d slower than avg
Panel avg: 122d · This submission: 426d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LPH Device Classification - Class 2, Special Controls

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 477
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K151424.
iTotal® Hip Replacement System
K162719 · Conformis, Inc. · Jun 2017
UTF Stem, reduced, #0, #00
K163193 · United Orthopedic Corporation · Jun 2017
Bencox M Stem Lateralized & Bencox Mirabo Cup System
K162127 · Corentec Co., Ltd. · Dec 2016
G7 Dual Mobility System, Active Articulation System
K161190 · Biomet, Inc. · May 2016
Stryker Orthopaedics Hip Systems Labeling Update
K153345 · Stryker Orthopaedics · May 2016
Bencox M Stem (Bencox Hip System) and Bencox ID Cemented Stem (with Centralizer) & Bencox Bone Plug
K152084 · Corentec Co., Ltd. · Apr 2016